$PBP - Probiotec Limited starting a new run?

Great steady growth throughout the year with a bit of a hiccup during the October volatility. Looks like it might be coming out of it after a retest of the lows.

Has better financials than most of the speculative stocks in the sector.

Probiotec Limited is engaged in the development, manufacture and sale of pharmaceuticals, consumer health and nutraceutical products in Australian and international markets. The Company's segments include Branded Pharmaceuticals, involving the sale of branded pharmaceutical products throughout Australia and also to selected South East Asian countries; Contract manufacture, involving the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies; Obesity and weight management, involving the manufacture and sale of a range of products across a number of channels, including fast moving consumer goods, pharmacy, health food stores and online; Europe, involving the manufacture and sale of products within Europe, and Specialty products, involving the sale of human and animal nutrition products, incorporating the sale of ingredients and additives for use in the pharmaceutical and food industries.